From: A mosaic genetic screen for novel mutations affecting Drosophila neuroblast divisions
Group | Alleles | Gene/lethal deficiency | Cytology | Further mapping data/Comments |
---|---|---|---|---|
Asymmetric cell division defects | ||||
1 | PL26i | Df(3R)p712 | 84D4;85B6 | No phenotype is observed in PL26/Df(3R)p712 hemizygotes |
6 | PL17i | ida | Â | Â |
13 | J16 | Not in deficiency kit | 3L | Also carries a mutation in polo |
8 | D76 | Not in deficiency kit | 61F8;72D1ii | Lethality is caused by a mutation in trio which does not cause the Miranda phenotype |
Cell division defects | ||||
 | Proliferation defects | |||
2 | LVC73i | Df(3L)GN24 or Df(3L)st-f13 | 63F4;64C15 or 72C1;73A4 | Â |
3 | PL13i | Df(3R)WIN11 or Df(3R)Dr-rv1 | 83E1;84A5 or 99A1;B11 | Â |
6 | PL17i | ida | Â | Â |
7 | A55, GL72 | small-minded | Â | Â |
8 | D76 | Df(3L)Ar14-8 | 61C5;62A8 | Lethality in this region is caused by a mutation in trio |
9 | A38, B10, B18 | Df(3L)Exel6112 + Df(3L)ED4408 | 66B5;66C5 | Â |
10 | A57 | Df(3L)ZN47 or Df(3L)fz-GF3b | 64C;65C or 70C1;D5 | Phenotype maps to 70C1;70D5 regionii |
11 | C10 | Df(3L)Ar14-8 or Df(3L)AC1 | 61C5;62A8 or 67A2;D13 | Phenotype maps to 67A2;67D13 regionii |
12 | E45 | makos | Â | Â |
 | Chromosome separation defects | |||
14 | A9, A67, B14, H10, DL42 | Klp61F | Â | Â |
15 | G34 | Df(3l)ri-XT1 | 77E2;78A4 | Complements Df(3L) ED4861, Df(3L)ME107 |
16 | C93 | separase | Â | Hemizogotes show multiple crescents of Miranda |
 | Multinucleate cells | |||
5 | D97, CMV111i, IV61i | sticky | Â | Â |
17 | C33 | pebble | Â | Â |
18 | A59, H2, GL22, C22 | Taf-4 | Â | Â |
19 | A42 | Df(3L)ED4858 + Df(3L)Exel6136 | 77B2;77C1 | Â |
20 | B27, H87 | Df(3L)BSC13 + Df(3L)ED4408 | 66B12;66C5 | Â |
21 | C26, C36 | Df(3L)XDI98 | 65A2;65E1 | Complements Df(3L)ZN47 and Df(3L)BSC27 |
22 | D7, CL89 | Df(3L)GN34 + Df(3L)ED4341 | 63F6;64A9 | Complements Df(3L)Exel6099 |
23 | D24 | Df(3L)Exel7253 | 73D5;73E4 | Â |
24 | D67, OL77 | Df(3L)ri-XT1 | 77E2;78A4 | Complements Df(3L)ED4861 |
25 | D75 | Df(3L)R-G7 or Df(3L)vin7 + Df(3L)eygC1or Df(3L)fz-M21 + Df(3L)XG-5 | 62B8;F5 or 69A4;B5 or 71C2;E5 | Â |
26 | F58 | Df(3L)BSC33 | 65E10;65F6 | Â |
27 | GL45 | Df(3L)Exel6105 | 64D1;64D6 | Â |
28 | H67, J2 | Df(3L)Exel6087 | 62A2;62A7 | Complements Df(3L)ED4238 |
29 | D40 | 7 lethal deficiencies in 4 lethal regions | 63C2;F7 or 65F3;F6 or 66B8;C5 or 66E1;E6 | Â |
30 | B55 | Not in deficiency kit | 3L | Â |
31 | E47, GL26 | Not in deficiency kit | 3L | Â |
 | Vesicular/membrane defects | |||
32 | B44, C19, C62 | Aats-ile | Â | Â |
33 | A69 | Int6 | Â | Â |
34 | D56 | neurexin | Â | Multinucleate cells are also observed with low frequency |
35 | E25, E55 | reptin | Â | Â |
36 | B11, O29 | Taf-6 | Â | Â |
37 | A11, A572, A58, E80, O49 | Df(3L)X-21.2 | 71F1;72A2 | Â |
38 | A44 | Df(3L)GN24 or Df(3L)vin5 + Df(3L)vin7 or Df(3L)fz-M21 | 63F4;64C15 or 68C8;69A3 or 70D2;71E5 | Â |
39 | OL61 | Df(3L)AC1 | 67A2;67D13 | Â |
40 | B29, H26 | Df(3L)ED4858 | 76E1;76F1 | Complements Df(3L)ED229 and Df(3L)ED4861 |
41 | CMV45, ML72 | Df(3L)rdgC-co2 | 77C6;77D1 | Complements Df(3L)ED4858 and Df(3L)Exel6136 |
42 | M7 | Df(3L)66C-G28 or Df(3L)rdgC-co2 + Df(3L)ri-79c | 66B8;C10 or 77B;D1 | Â |
43 | OL24 | Df(3L)X-21.2 | 71F1;72A2 | Â |
44 | CL62 | Df(3L)ED4858 | 76D3;77C1 | Â |
45 | F582, G82, ML72 | Df(3L)Exel6132 + Df(3L)Exel9005 | 74B2;74D2 | ML72 is also allelic to CMV45 (group 41) |
46 | GL29 | Df(3L)ZP1 or Df(3L)ED218 | 66A17;C5 or 71B1;E1 | Phenotype maps to 71B1;71E1 regionii; complements Df(3L)Exel6125 |
47 | A41, E50 | not in deficiency kit | 3L | Â |
48 | B57 | n.d. | 3L | Â |
4 | C79 | n.d. | 3L | Â |